Vinva Investment Management Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1968109 SYDNEY, C3

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,508,388

+$10,025,413 QoQ

Shares Held

34,494

+132.1% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#207

of 1,329 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Vinva Investment Management Ltd holds $143,806,233 across 13 Biotechnology names. REGN ranks #3 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	462,843	$52,467,882
2	ALNY	Alnylam Pharmaceuticals, Inc.	154,972	$46,651,221
3	REGN	Regeneron Pharmaceuticals, Inc. This page	34,494	$21,508,388
4	VRTX	Vertex Pharmaceuticals Inc / Ma	30,687	$15,243,153
5	HALO	Halozyme Therapeutics, Inc.	24,835	$1,943,835
6	EXEL	Exelixis, Inc.	31,102	$1,692,259
7	ASND	Ascendis Pharma A/S	4,536	$1,209,841
8	BMRN	Biomarin Pharmaceutical Inc	19,569	$1,119,738

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,508,388	34,494	+132.1%	Shares	Sole	2026-08-14
2026-03-31	$11,482,975	14,862	+7.0%	Shares	Sole	2026-05-14
2025-12-31	$10,721,274	13,890	+58.3%	Shares	Sole	2026-02-17
2025-09-30	$4,933,919	8,775	+31.3%	Shares	Sole	2025-11-13
2025-06-30	$3,508,050	6,682	+21.5%	Shares	Sole	2025-08-13
2025-03-31	$3,488,265	5,500	+45.5%	Shares	Sole	2025-05-14
2024-12-31	$2,691,895	3,779	+45.5%	Shares	Sole	2025-02-11
2024-09-30	$2,730,070	2,597	-28.9%	Shares	Sole	2024-11-14
2024-06-30	$3,838,361	3,652	-10.0%	Shares	Sole	2024-08-13
2024-03-31	$3,904,821	4,057	+9.7%	Shares	Sole	2024-05-13
2023-12-31	$3,247,916	3,698	+16.7%	Shares	Sole	2024-02-13
2023-09-30	$2,607,137	3,168	-0.3%	Shares	Sole	2023-11-13
2023-06-30	$2,283,520	3,178	-13.0%	Shares	Sole	2023-08-14
2023-03-31	$3,001,560	3,653	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.